Back to Search
Start Over
Phase 1 study of peptide receptor radionuclide therapy (PRRT) with [Y-90-DOTA,Tyr(3)]octreotide in patients with somatostatin receptor positive tumors
- Source :
- Cancer Biotherapy & Radiopharmaceuticals, Vol. 18, no. 2, p. 295-295 (2003)
- Publication Year :
- 2003
Details
- Database :
- OAIster
- Journal :
- Cancer Biotherapy & Radiopharmaceuticals, Vol. 18, no. 2, p. 295-295 (2003)
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1130549300
- Document Type :
- Electronic Resource